↓ Skip to main content

Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems

Overview of attention for article published in JAMA: Journal of the American Medical Association, June 2015
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
42 news outlets
blogs
6 blogs
policy
2 policy sources
twitter
655 tweeters
patent
6 patents
facebook
38 Facebook pages
wikipedia
1 Wikipedia page
googleplus
4 Google+ users
reddit
1 Redditor

Citations

dimensions_citation
385 Dimensions

Readers on

mendeley
901 Mendeley
citeulike
1 CiteULike
Title
Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems
Published in
JAMA: Journal of the American Medical Association, June 2015
DOI 10.1001/jama.2015.6199
Pubmed ID
Authors

Kevin P. Hill

Abstract

As of March 2015, 23 states and the District of Columbia had medical marijuana laws in place. Physicians should know both the scientific rationale and the practical implications for medical marijuana laws. To review the pharmacology, indications, and laws related to medical marijuana use. The medical literature on medical marijuana was reviewed from 1948 to March 2015 via MEDLINE with an emphasis on 28 randomized clinical trials of cannabinoids as pharmacotherapy for indications other than those for which there are 2 US Food and Drug Administration-approved cannabinoids (dronabinol and nabilone), which include nausea and vomiting associated with chemotherapy and appetite stimulation in wasting illnesses. Use of marijuana for chronic pain, neuropathic pain, and spasticity due to multiple sclerosis is supported by high-quality evidence. Six trials that included 325 patients examined chronic pain, 6 trials that included 396 patients investigated neuropathic pain, and 12 trials that included 1600 patients focused on multiple sclerosis. Several of these trials had positive results, suggesting that marijuana or cannabinoids may be efficacious for these indications. Medical marijuana is used to treat a host of indications, a few of which have evidence to support treatment with marijuana and many that do not. Physicians should educate patients about medical marijuana to ensure that it is used appropriately and that patients will benefit from its use.

Twitter Demographics

The data shown below were collected from the profiles of 655 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 901 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 6 <1%
Colombia 1 <1%
Australia 1 <1%
Chile 1 <1%
Spain 1 <1%
Canada 1 <1%
Unknown 890 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 150 17%
Researcher 103 11%
Student > Master 102 11%
Other 98 11%
Student > Ph. D. Student 77 9%
Other 232 26%
Unknown 139 15%
Readers by discipline Count As %
Medicine and Dentistry 269 30%
Psychology 74 8%
Agricultural and Biological Sciences 57 6%
Nursing and Health Professions 53 6%
Pharmacology, Toxicology and Pharmaceutical Science 51 6%
Other 218 24%
Unknown 179 20%

Attention Score in Context

This research output has an Altmetric Attention Score of 857. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 May 2022.
All research outputs
#15,497
of 21,749,011 outputs
Outputs from JAMA: Journal of the American Medical Association
#424
of 32,085 outputs
Outputs of similar age
#122
of 246,583 outputs
Outputs of similar age from JAMA: Journal of the American Medical Association
#5
of 427 outputs
Altmetric has tracked 21,749,011 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,085 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 71.7. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 246,583 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 427 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.